These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 14520125)
1. Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study. Wallaschofski H; Eigenthaler M; Kiefer M; Donné M; Hentschel B; Gertz HJ; Lohmann T J Clin Psychopharmacol; 2003 Oct; 23(5):479-83. PubMed ID: 14520125 [TBL] [Abstract][Full Text] [Related]
2. Differences in platelet activation by prolactin and leptin. Wallaschofski H; Kobsar A; Sokolova O; Siegemund A; Stepan H; Faber R; Eigenthaler M; Lohmann T Horm Metab Res; 2004 Jul; 36(7):453-7. PubMed ID: 15305227 [TBL] [Abstract][Full Text] [Related]
4. Enhanced platelet activation by prolactin in patients with ischemic stroke. Wallaschofski H; Lohmann T; Hild E; Kobsar A; Siegemund A; Spilcke-Liss E; Hentschel B; Stumpf C; Daniel WG; Garlichs CD; Eigenthaler M Thromb Haemost; 2006 Jul; 96(1):38-44. PubMed ID: 16807649 [TBL] [Abstract][Full Text] [Related]
5. PRL as a novel potent cofactor for platelet aggregation. Wallaschofski H; Donné M; Eigenthaler M; Hentschel B; Faber R; Stepan H; Koksch M; Lohmann T J Clin Endocrinol Metab; 2001 Dec; 86(12):5912-9. PubMed ID: 11739463 [TBL] [Abstract][Full Text] [Related]
6. Effects of prolactin on platelet activation and blood clotting. Wahlberg J; Tillmar L; Ekman B; Lindahl TL; Landberg E Scand J Clin Lab Invest; 2013 Apr; 73(3):221-8. PubMed ID: 23570413 [TBL] [Abstract][Full Text] [Related]
7. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey. Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438 [TBL] [Abstract][Full Text] [Related]
8. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia. Poyraz BC; Aksoy C; Balcioğlu I Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008 [TBL] [Abstract][Full Text] [Related]
9. Co-activation of platelets by prolactin or leptin--pathophysiological findings and clinical implications. Wallaschofski H; Kobsar A; Sokolova O; Eigenthaler M; Lohmann T Horm Metab Res; 2004 Jan; 36(1):1-6. PubMed ID: 14983399 [TBL] [Abstract][Full Text] [Related]
10. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia. Nakajima M; Terao T; Iwata N; Nakamura J Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461 [TBL] [Abstract][Full Text] [Related]
11. Risk of venous thromboembolism due to antipsychotic drug therapy. Hägg S; Jönsson AK; Spigset O Expert Opin Drug Saf; 2009 Sep; 8(5):537-47. PubMed ID: 19569978 [TBL] [Abstract][Full Text] [Related]
12. Hyperprolactinemia and atypical antipsychotic therapy in a case of fatal thromboembolism. Rousseau AM J Clin Psychopharmacol; 2010 Dec; 30(6):734-5. PubMed ID: 21057237 [No Abstract] [Full Text] [Related]
13. Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression. Raaz D; Wallaschofski H; Stumpf C; Yilmaz A; Cicha I; Klinghammer L; Daniel WG; Lohmann T; Garlichs CD Horm Metab Res; 2006 Nov; 38(11):767-72. PubMed ID: 17111306 [TBL] [Abstract][Full Text] [Related]